Paul D. Rubin
2016 - XOMA
In 2016, Paul D. Rubin earned a total compensation of $636.1K as Former Senior Vice President Research and Development and Chief Medical Officer at XOMA, a 41% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $97,271 |
|---|---|
| Salary | $382,776 |
| Stock Awards | $151,346 |
| Other | $4,713 |
| Total | $636,106 |
Rubin received $382.8K in salary, accounting for 60% of the total pay in 2016.
Rubin also received $97.3K in non-equity incentive plan, $151.3K in stock awards and $4.7K in other compensation.
Rankings
In 2016, Paul D. Rubin's compensation ranked 10,309th out of 14,075 executives tracked by ExecPay. In other words, Rubin earned more than 26.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,309 out of 14,075 | 27th |
Division Manufacturing | 3,983 out of 5,489 | 27th |
Major group Chemicals And Allied Products | 1,402 out of 1,895 | 26th |
Industry group Drugs | 1,121 out of 1,538 | 27th |
Industry Pharmaceutical Preparations | 878 out of 1,176 | 25th |
Source: SEC filing on April 5, 2017.
Rubin's colleagues
We found four more compensation records of executives who worked with Paul D. Rubin at XOMA in 2016.